 apheresis-elutri program adopt immunotherapi autolog monocyt cancer patient human blood monocyt Mo monocyte-deriv macrophag phi potent antitumor cytotox effector cell activ recombin human interferon gamma rifn-gamma bacteri muramyldipeptid synthet deriv muramyltripeptid phosphatidylethanolamin liposom l-mtp-pe large-scal gener ex vivo Mo blood cancer patient feasibl experi fix rotor speed counterflow centrifug elutr cee procedur avail beckman high capac rotor system Mo puriti suspens intact peripher blood mononuclear cell-enrich suspens leukapheresi LP healthi volunt cancer patient semiclos easi cce system steril techniqu clinic trial adopt monocyt immunotherapi isol Mo morpholog function integr spontan activ abil activ cytotox state stimul u/ml rifn-gamma microgram/ml l-mtp-pe matur phi vitro system larg number Mo phase clinic trial intraperiton immunotherapi l-mtp-pe autolog Mo patient periton carcinomatosi patient weekli Mo infus intrapati dose escal schedul Mo mild fever chill abdomin pain treatment-induc thromboembol event capillari leak syndrom